{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:14:12Z","timestamp":1792084452224,"version":"4.4.0"},"reference-count":26,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Ophthalmology"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>This study aims to describe the impact on survival of non-exenteration management of orbital disease, supplemented with transcutaneous retrobulbar injection of amphotericin B (TRAMB), in a cohort of patients with COVID-19-associated ROCM, a life-threatening condition for which exenteration is generally the preferred treatment modality.<\/jats:p>\n                    <jats:p>\n                      <jats:bold>Method<\/jats:bold>\n                      : This retrospective cohort study included 69 COVID-19-associated ROCM patients. All patients were treated with intravenous liposomal amphotericin-B and surgical debridement of paranasal sinuses. All patients with orbital disease were treated with TRAMB (42\/69); orbital debridement or extended enucleation was performed when the disease was severe or progressive; debridement of intracranial disease was done when indicated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the 69 patients included, at discharge, 45\/69(65.2%) had cured\/stable ROCM, 13\/69(18.8%) died and 11\/69(15.94%) were discharged on request, with progressive disease. The vision was preserved in 45\/69(65%), a blind eye with preserved ocular globe in 18\/69(26%), and 6\/69(9%) underwent extended enucleation. At 18 months follow-up, 6\/56 died, 13\/56 were lost to follow-up and 37\/56 were alive. The cumulative mortality was 27% (19\/69). Independent risk factors for mortality were increasing age(\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.003), diabetic ketoacidosis(\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.006), severe COVID-19 (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.04), and CNS involvement (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this study, conservative orbit management sans exenteration augmented with retrobulbar injection of amphotericin B was an effective treatment modality for orbital involvement in ROCM. The mortality in our patients was comparable to reports where exenteration was the first line of treatment, with better vision and cosmetic outcomes. Further studies comparing orbit conservation with TRAMB versus exenteration may be needed to delineate further, whether this approach can be an alternative to exenteration.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/11206721251361276","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T06:44:39Z","timestamp":1753944279000},"page":"81-88","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Orbit management sans exenteration with retrobulbar injection of amphotericin-B in Rhinoorbitocerebral mucormycosis: Impact on survival"],"prefix":"10.1177","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4140-5672","authenticated-orcid":false,"given":"Shubashree","family":"Karat","sequence":"first","affiliation":[{"name":"St John's Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2822-9555","authenticated-orcid":false,"given":"Aaron Charles","family":"Lobo","sequence":"additional","affiliation":[{"name":"St John's Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9472-8361","authenticated-orcid":false,"given":"Anita","family":"Ross","sequence":"additional","affiliation":[{"name":"St John's Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8711-322X","authenticated-orcid":false,"given":"Anna","family":"Philip","sequence":"additional","affiliation":[{"name":"St John's Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1785-5481","authenticated-orcid":false,"given":"Thenmozhi","family":"Nagarajan","sequence":"additional","affiliation":[{"name":"St John's Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4829-1655","authenticated-orcid":false,"given":"Suneetha","family":"Nithyanandam","sequence":"additional","affiliation":[{"name":"St John's Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,7,30]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.3390\/jof6040265"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_1565_21"},{"key":"e_1_3_2_4_2","unstructured":"World Health Organization. WHO Coronavirus (COVID-19) Dashboard: India https:\/\/covid19.who.int\/region\/searo\/country\/in (2023 accessed February 2023)."},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mycmed.2023.101393"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30312-3"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0000000000002030"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2021.5201"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_1767_21"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-022-07544-y"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/myc.13435"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.18203\/issn.2454-5929.ijohns20230104"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/lary.23912"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.iop.0000225418.50441.ee"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0000000000000812"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2018-312688"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0000000000001357"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12070-018-1293-8"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-022-07620-3"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2021.05.025"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0000000000002256"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_1382_22"},{"key":"e_1_3_2_23_2","first-page":"231","article-title":"Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes","volume":"51","author":"Nithyanandam S","year":"2003","unstructured":"Nithyanandam S, Jacob MS, Battu RR, et al. Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes. Indian J Ophthalmol 2003; 51: 231\u2013236.","journal-title":"Indian J Ophthalmol"},{"key":"e_1_3_2_24_2","unstructured":"World Health Organization. World Health Organization. COVID-19 clinical management: living guidance. World Health Organization https:\/\/iris.who.int\/handle\/10665\/338882 (25 January 2021 accessed May 2024)."},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_448_22"},{"key":"e_1_3_2_26_2","article-title":"Reconstruction in rhino-orbito-cerebral mucormycosis survivors: a systematic review","volume":"22","author":"Cheruvu Rao VP","year":"2022","unstructured":"Cheruvu Rao VP, Khan KK. Reconstruction in rhino-orbito-cerebral mucormycosis survivors: a systematic review. Index ePlasty 2022; 22: e20.","journal-title":"Index ePlasty"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.4103\/0972-4052.167947"}],"container-title":["European Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/11206721251361276","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/11206721251361276","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/11206721251361276","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T19:41:31Z","timestamp":1777405291000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/11206721251361276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,30]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1177\/11206721251361276"],"URL":"https:\/\/doi.org\/10.1177\/11206721251361276","relation":{},"ISSN":["1120-6721","1724-6016"],"issn-type":[{"value":"1120-6721","type":"print"},{"value":"1724-6016","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,30]]}}}